Pay in 4 interest-free payments of $28.26 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
4-diethoxyphenyl)-1
we temporally name it as MDK-0264
and significance attributed to thin hazes of bacterial survival
CW-069 shows statistically significant selectivity over KSP
PubMed PMID: 27696405
PHA-848125 - CAS# 802539-81-7 Catalog No.:M10691-10 4-diethoxyphenyl)-1Milciclib, also known as PHA 848125 or PHA 848125AC, is an orally bioavailable inhibitor of cyclin dependent kinases (CDKs) and thropomyosin receptor kinase A (TRKA), with potential antineoplastic activity. CDK2 TRKA inhibitor PHA 848125 AC potently inhibits cyclin dependent kinase 2 (CDK2) and exhibits activity against other CDKs including CDK1 and CDK4, in addition to TRKA. Inhibition of these kinases may result in cell cycle arrest and apoptosis of
US$ 82.00
US$ 79.00
US$ 177.50
US$ 34.99
US$ 109.99